Expression of indoleamine 2,3-dioxygenase in skeletal muscle cells and its possible role in idiopathic inflammatory diseases.

Vol. 1 2024 - 317792
Poster - V Workshop on Inflammation
Favorite this paper
How to cite this paper?
Abstract

Dermatomyositis (DM) is a subclassification of idiopathic inflammatory myopathy, characterized by progressive muscle atrophy and degeneration, accompanied by extramuscular symptoms such as bluish-purple skin lesions. The enzyme Indoleamine 2,3-Dioxygenase 1 (IDO1) is described in the literature as promoting immune tolerance, mediated by the depletion of Tryptophan (Trp) and the synthesis of Kynurenine (Kyn), generating a cascade of metabolites with bioactive functions that modulate the immune response. This study aims to investigate the expression and functional role of IDO1 in skeletal muscle cells and its possible function in inflammatory conditions associated with Dermatomyositis. To this end, immortalized skeletal muscle cells (CL48) were cultured and divided into four experimental groups: the control group, stimulated with LPS, treated with the IDO1 inhibitor (MDT) and/or 1-methyltryptophan (1-MT), and a combined MDT/1-MT with LPS group. Additional pro-inflammatory cytokines as stimuli were also incubated with the inhibitors to assess responses in myoblasts. Initial results suggest a reduction in cell viability with higher doses of MDT, as well as a reduction in cell proliferation when inflammatory stimuli are incubated with the inhibitors. Preliminary assays indicated a reduction in cell viability associated with the increase in IDO1 inhibitor concentration in proliferating skeletal muscle cells. Preliminary assays evaluating cell proliferation and viability showed reduced cytokine levels when MDT/1-MT was combined with LPS or other inflammatory cytokines, compared to the group stimulated with LPS alone. The initial results suggest that IDO1 plays a significant role in modulating inflammation, possibly preventing exacerbated inflammation in skeletal muscle tissue. These findings indicate a potential relevance of IDO1 in the pathophysiology of dermatomyositis and open new perspectives for targeted therapies for myopathies.

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 Universidade Federal do Rio de Janeiro
  • 2 Instituto de Ciências Biomédicas - UFRJ
  • 3 UFRJ
Track
  • Mechanisms of the Inflammatory Response
Keywords
Indoleamine 2,3-dioxygenase
Skeletal muscle
Dermatomyositis